This store requires javascript to be enabled for some features to work correctly.
Boost your hair growth
Men and women disappointed with minoxidil products often enjoy better results from Spectral.DNC-N® because it contains novel active ingredients that work through complementary pathways and have no reported side effects. Spectral.DNC-N® enables patients to maintain healthy-looking hair while promoting hair growth in the desired areas. It often works faster and more effectively for men and women who did not respond well to standard leave-in treatments.
-
5% Nanoxidil® topical treatment for hair loss
The alternative to Minoxidil developed first by DS Laboratories, Nanoxidil® employs a complex matrix to open ion channels in hair follicles, with a lighter molecular weight to enhance its bioavailability.
-
Water-Based Formula (non-greasy)
Unlike Minoxidil, our formula is Propylene glycol free, an agent that commonly causes irritation and contact dermatitis, with even more frequent complaints of promoting greasy hair.
-
Blocks DHT Formation
DHT is a major cause and the responsible for male pattern hair loss linked to genetics and aging. Caffeine and Azelaic Acid block the conversion from testosterone to DHT.
-
Prevents Hair Loss
Our exclusive formula helps stop hair loss and stop the natural progression; in some cases, it can help grow new hair.
-
Frontal & Vertex
Our unique formulation helps prevent hair loss and stimulates the growth not only in the vertex, like Minoxidil but in the whole head.
-
Advanced Nanosome delivery of ingredients
Our proprietary Nanosome delivery technology encapsulates key compounds in microscopic liposomes to penetrate deeper into epidermal cells for maximum results.
Clinical Studies
First and foremost, DS Laboratories is a technology company aggressively focused on innovation. All our products have active pharmaceutical ingredients that ensure the best quality and provide high added value in the care of hair problems.
- PERCEPTION STUDY 13 DECEMBER 2011
- Nanoxidil Study 22 JANUARY 2015
- Nanosome Study 18 NOVEMBER 2009
- Novel Treatments Research Article|Addressing Androgenetic Alopecia 10 OCTOBER 2018|27 AUGUST 2017
- EFFECTS OF A TOPICAL HAIR GROWTH PROMOTER CONTAINING 5% NANOXIDIL™
- PHASE II STUDY TO EVALUATE EFFICACY AND SAFETY OF PYRROLIDINYL DIAMINOPYRIMIDINE OXIDE PDPO TOPICAL SOLUTION
- RESULTS
- INGREDIENTS
- FAQ
Unlock Your Transformation: Witness the Journey
See All MoreAQUA, ALCOHOL DENAT., GLYCERETH-26, GLYCERIN, DISODIUM PHOSPHATE, AZELAIC ACID, CAFFEINE, POLYSORBATE 80, ADENOSINE, PYRROLIDINYL DIAMINOPYRIMIDINE OXIDE, PHENOXYETHANOL, COPPER TRIPEPTIDE-1, CAPRYLYL GLYCOL, PHOSPHOLIPIDS, PARFUM, PIROCTONE OLAMINE, MENTHOL, MYRISTOYL PENTAPEPTIDE-17, LECITHIN, LYSOPHOSPHATIDIC ACID, LYSOLECITHIN, RETINOL, BUTYLPHENYL METHYLPROPIONAL, LINALOOL, HEXYL CINNAMAL, BENZYL BENZOATE, CITRONELLOL, BENZYL CINNAMATE
Can I cancel my subscription?
YES, you can cancel your subscription ANYTIME. No commitments. It’s extremely easy to cancel with us through email or phone.
How long until I see results?
Customers usually see results within the first 90 days in terms of overall better hair health and seeing hair growth or lessen their hair loss from the regiment between shampoo, serums, and supplements.
Do these products cause any side effects?
These products are not KNOWN to cause any side effects. However, please do read the ingredients section if you have any known allergies. If you have sensitive skin, please consult with a dermatologist.
How long does it take to ship my order?
Orders are processed and shipped within the first 24-48 hours of entering our system. You will get a tracking number by email when your order has been shipped.

why subscribe?
SAVE ON EVERY ORDER
Make this product a part of your permanent routine!
- Monthly savings (15%-20%)
- Free shipping on all US orders
- Consistency = success
- Save time. Buy once, we'll do all the work. It's that simple.
Client reviews
Here’s why our products are chosen by millions of people worldwide and are unlike anything you have come across yet.


